ANDA 75395, held by Zydus Hlthcare. Isosorbide Mononitrate.
As of Nov 16, 2026, ANDA 75395 (Isosorbide Mononitrate), held by Zydus Hlthcare, was first approved by FDA on Mar 16, 2000, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 16, 2000 | Original application | Approved |
| Isosorbide Mononitrate30MG · tablet, extended release;oral | Isosorbide Mononitrate | Rx |
| Isosorbide Mononitrate60MG · tablet, extended release;oral | Isosorbide Mononitrate | Rx |
| Isosorbide Mononitrate120MG · tablet, extended release;oral | Isosorbide Mononitrate | Rx |
| Mar 4, 2015 | Supplement 25Labeling | Approved | None posted |
| Oct 31, 2007 | Supplement 18Labeling | Approved | None posted |
| Jun 14, 2007 | Supplement 13Labeling | Approved | None posted |
| Jun 14, 2007 | Supplement 12Manufacturing | Approved | None posted |
| Sep 9, 2002 | Supplement 6Manufacturing | Approved | None posted |
| Sep 9, 2002 | Supplement 5Manufacturing | Approved | None posted |
| Aug 23, 2002 | Supplement 4Manufacturing | Approved | None posted |
| Feb 19, 2002 | Supplement 3Manufacturing | Approved | None posted |
| Mar 23, 2001 | Supplement 2Manufacturing | Approved | None posted |
| Aug 10, 2000 | Supplement 1Manufacturing | Approved | None posted |
| Mar 16, 2000 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters